<div id="readability-page-1"><p><span>UnitedHealth Group (NYSE:UNH - Get Free Report)</span> had its price target decreased by research analysts at Mizuho  from $515.00 to $350.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an &#34;outperform&#34; rating on the healthcare conglomerate's stock. Mizuho's price objective indicates a potential upside of 21.37% from the stock's previous close.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>MarketBeat Week in Review – 05/12 - 05/16</li></ul><p>UNH has been the subject of several other research reports. JPMorgan Chase &amp; Co. reduced their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an &#34;overweight&#34; rating for the company in a research note on Thursday. Hsbc Global Res cut UnitedHealth Group from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, April 22nd. Argus downgraded UnitedHealth Group from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Monday, April 21st. Barclays decreased their price objective on UnitedHealth Group from $513.00 to $362.00 and set an &#34;overweight&#34; rating on the stock in a report on Thursday. Finally, KeyCorp cut their price target on shares of UnitedHealth Group from $575.00 to $450.00 and set an &#34;overweight&#34; rating for the company in a report on Wednesday. Six investment analysts have rated the stock with a hold rating, eighteen have assigned  a buy rating and one  has given a strong buy rating to the company's stock. According to data from MarketBeat, the company  has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $486.00.</p><p><b>Check Out Our Latest Research Report on UNH</b></p><h2>UnitedHealth Group Price Performance</h2><ul><li>3 Stocks to Buy Now for Tariff Immunity</li></ul><p>NYSE UNH traded up $14.02 on Friday, reaching $288.37. The company's stock had a trading volume of 50,680,475 shares, compared to its average volume of 5,783,106. UnitedHealth Group has a twelve month low of $248.88 and a twelve month high of $630.73. The stock has a market cap of $261.59 billion, a PE ratio of 18.54, a PEG ratio of 1.37 and a beta of 0.56. The firm's 50 day moving average is $474.72 and its two-hundred day moving average is $515.82. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. </p><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the prior year, the business posted $6.91 EPS.  As a group, sell-side analysts predict that  UnitedHealth Group will post 29.54 EPS for the current year. </p><h2>Hedge Funds Weigh In On UnitedHealth Group</h2><ul><li>UnitedHealth Group: Pariah to Pole Position to Buy the Dip Levels</li></ul><p>Several institutional investors have recently modified their holdings of the business. Financial Management Professionals Inc. raised its holdings in shares of  UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after acquiring an additional 17 shares during the period.  Western Pacific Wealth Management LP lifted its holdings in shares of  UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock valued at $456,000 after purchasing an additional 19 shares in the last quarter.  MCF Advisors LLC raised its position in  UnitedHealth Group by 0.8% in the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock valued at $1,304,000 after buying an additional 20 shares during the last quarter.  Axiom Financial Strategies LLC boosted its position in  UnitedHealth Group by 3.6% during the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock worth $291,000 after acquiring an additional 20 shares during the last quarter.  Finally, Richwood Investment Advisors LLC lifted its position in shares of  UnitedHealth Group by 0.4% in the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after purchasing an additional 20 shares in the last quarter. Institutional investors own  87.86% of the company's stock. </p><h2>UnitedHealth Group Company Profile</h2> (Get Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>TSX Venture Exchange (Formerly Canadian Venture Exchange)</li><li>Retail Investors Are Betting Big on Rocket Lab—Should You Too?</li><li>Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?</li><li>GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine</li><li>High Flyers: 3 Natural Gas Stocks for March 2022</li><li>Taiwan Semiconductor Stock Is The Gift That Keeps on Giving</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Mizuho has lowered its price target for UnitedHealth Group (NYSE: UNH) from $515 to $350, maintaining an "outperform" rating. This adjustment suggests a potential upside of 21.37% from the stock's previous close. Other analysts have also revised their targets, with JPMorgan reducing theirs to $405 and Barclays to $362. Currently, the stock is trading at $288.37, with a market cap of $261.59 billion. UnitedHealth reported earnings of $7.20 per share, missing estimates, and has a consensus price target of $486.</p>

Mizuho Has Lowered Expectations for UnitedHealth Group (NYSE:UNH) Stock Price